| 3-Methylthiazolo [3, 2-a] benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and … AAM Alkhaldi, MM Al-Sanea, A Nocentini, WM Eldehna, ZM Elsayed, ... European Journal of Medicinal Chemistry 207, 112745, 2020 | 49 | 2020 |
| Benzofuran-based carboxylic acids as carbonic anhydrase inhibitors and antiproliferative agents against breast cancer WM Eldehna, A Nocentini, ZM Elsayed, T Al-Warhi, N Aljaeed, OJ Alotaibi, ... ACS Medicinal Chemistry Letters 11 (5), 1022-1027, 2020 | 42 | 2020 |
| Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria ZM Elsayed, WM Eldehna, MM Abdel-Aziz, MA El Hassab, EB Elkaeed, ... Journal of enzyme inhibition and medicinal chemistry 36 (1), 384-392, 2021 | 41 | 2021 |
| Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors M Shaldam, WM Eldehna, A Nocentini, ZM Elsayed, TM Ibrahim, R Salem, ... European Journal of Medicinal Chemistry 216, 113283, 2021 | 40 | 2021 |
| Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR … WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi, H Elkady, ... Scientific reports 12 (1), 12821, 2022 | 38 | 2022 |
| Design, synthesis and biological evaluation of new HDAC1 and HDAC2 inhibitors endowed with ligustrazine as a novel cap moiety MM Al-Sanea, L Gotina, MFA Mohamed, D Grace Thomas Parambi, ... Drug design, development and therapy, 497-508, 2020 | 37 | 2020 |
| Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer WM Eldehna, R Salem, ZM Elsayed, T Al-Warhi, HR Knany, RR Ayyad, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1423-1434, 2021 | 25 | 2021 |
| Development of 3-methyl/3-(morpholinomethyl) benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells MM Al-Sanea, GH Al-Ansary, ZM Elsayed, RM Maklad, EB Elkaeed, ... Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 987-999, 2021 | 21 | 2021 |
| Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens T Al-Warhi, DM Elimam, ZM Elsayed, MM Abdel-Aziz, RM Maklad, ... RSC advances 12 (48), 31466-31477, 2022 | 18 | 2022 |
| Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis WM Eldehna, MA El Hassab, NA Abdelshafi, FAZ Sayed, M Fares, ... International Journal of Pharmaceutics 612, 121369, 2022 | 16 | 2022 |
| Development of novel quinoline-based sulfonamides as selective cancer-associated carbonic anhydrase isoform IX inhibitors M Shaldam, A Nocentini, ZM Elsayed, TM Ibrahim, R Salem, ... International Journal of Molecular Sciences 22 (20), 11119, 2021 | 16 | 2021 |
| Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors MA Shaldam, H Almahli, A Angeli, RM Badi, EF Khaleel, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2203389, 2023 | 13 | 2023 |
| Novel 2-(5-Aryl-4, 5-dihydropyrazol-1-yl) thiazol-4-one as EGFR inhibitors: synthesis, biological assessment and molecular docking insights T Al-Warhi, AM El Kerdawy, MA Said, A Albohy, ZM Elsayed, N Aljaeed, ... Drug Design, Development and Therapy, 1457-1471, 2023 | 13 | 2023 |
| Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease MH ElNaggar, AA Elgazar, G Gamal, SM Hamed, ZM Elsayed, ... Journal of enzyme inhibition and medicinal chemistry 38 (1), 2234665, 2023 | 6 | 2023 |
| 1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights T Al-Warhi, H Almahli, RM Maklad, ZM Elsayed, MA El Hassab, ... Molecules 28 (7), 3203, 2023 | 6 | 2023 |
| Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors WM Eldehna, MA El Hassab, NA Abdelshafi, RA Eissa, NH Diab, ... International Journal of Pharmaceutics 631, 122537, 2023 | 6 | 2023 |
| Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors ZM Elsayed, H Almahli, A Nocentini, A Ammara, CT Supuran, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2191163, 2023 | 4 | 2023 |
| Computational Prediction of the Potential Target of SARS‐CoV‐2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM‐PBSA Calculations MA El Hassab, LR Hemeda, ZM Elsayed, ST Al‐Rashood, ... Chemistry & Biodiversity 19 (2), e202100719, 2022 | 4 | 2022 |
| Design and synthesis of benzo[b]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis T Al‐Warhi, NM Rashad, H Almahli, MM Abdel‐Aziz, ZM Elsayed, ... Archiv der Pharmazie 357 (2), 2300529, 2024 | 2 | 2024 |
| Phthalimide‐tethered isatins as novel poly (ADP‐ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigations MA El Hassab, AAA El‐Hafeez, H Almahli, ZM Elsayed, WM Eldehna, ... Archiv der Pharmazie 357 (3), 2300599, 2024 | 1 | 2024 |
Wagdy M. EldehnaAssociate Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, EgyptVerified email at pharm.kfs.edu.eg
